Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome

European Archives of Psychiatry and Clinical Neuroscience

Volumn 252, Issue 4, 2002, Pages 185-194

  Saletu, M ^a   Anderer, P ^a   Saletu Zyhlarz, G ^a   Hauer, C ^a   Saletu, Bernd ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Polysomnography; Pramipexole; Psychometry; Restless legs syndrome; Sleep quality

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; PLACEBO; PRAMIPEXOLE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; LEG MOVEMENT; MALE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PSYCHOMETRY; REM SLEEP; RESTLESS LEGS SYNDROME; SINGLE BLIND PROCEDURE; SLEEP WAKING CYCLE; SLOW WAVE SLEEP; SOMNOLENCE; TREATMENT OUTCOME;

EID: 0036920027     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-002-0380-7     Document Type: Article

References (56)

1. Abt K (1988) Descriptive data analysis (DDA) in quantitative EEG studies. In: Samson-Dollfus D, Guieu JD, Gotman J, Etevenon P (eds) Statistics and Topography in Quantitative EEG. Elsevier, Amsterdam, pp 150-160
2. Allen RP, Earley CJ (1996) Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 19: 205-213
3. American Sleep Disorders Association (1997) The International Classification of Sleep Disorders, revised: Diagnostic and Coding Manual. Rochester, Minnesota
4. ASDA Atlas Task Force (1992) EEG arousals: scoring rules and examples. American Sleep Disorders Association and Sleep Research. Sleep 15: 173-184
5. ASDA Atlas Task Force (1993) Recording and scoring leg movements. Sleep 16: 749-759
6. Backhaus J, Hohagen F, Voderholzer U, Riemann D (2001) Long-term effectiveness of a short-term cognitive-behavioral group treatment for primary insomnia Eur Arch Psychiatry Clin Neurosci 251: 35-41
7. Bakshi R (1996) Fluoxetine and restless legs syndrome. J Neurol Sci 142: 151-152
8. Becker PM, Ondo W, Sharon D (1998) Encouraging initial response of restless legs syndrome to pramipexole. Neurology 51(4): 1221-1223
9. Brodeur C, Montplaisir J, Godbout R, Marinier R (1988) Treatment of restless legs syndrome and periodic movements during sleep with L-Dopa: a double-blind, controlled study. Neurology 38: 1845-1848
10. Buysse DJ, Reynolds III CF, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh sleep quality index. A new instrument for psychiatric practice and research. Psychiatry Res 28: 193-213
11. Coleman RM (1982) Periodic movements in sleep (nocturnal myoclonus) and restless legs syndrome. In: Guilleminault C (ed) Sleeping and Waking Disorders: Indications and Techniques. Addison-Wesley, Menlo Park, pp 265-295
12. Collado-Seidel V, Kazenwadel J, Wetter TC, Kohnen R, Winkelmann J, Selzer R, Oertel WH, Trenkwalder C (1999) A controlled study of additional sr-L-dopa in L-dopa responsive restless legs syndrome with late-night symptoms. Neurology 52: 285-290
13. Corrigan MH, Denahan AQ, Wright CE, Ragual RJ, Evans DL (2000) Comparison of pramipexole, fluoxetine, and placebo in patients with major depression. Depress Anxiety 11 (2): 58-65
14. Cross EM, Chaffin WW (1982) Use of the binomial theorem in interpreting results of multiple tests of significance. Educational and Psychological Measurement 42: 25-34
15. Ekbom KA (1945) Restless legs. Acta Med Scand 158: 1-123
16. Ferber G, Abt K, Fichte K, Luthringer R (1999) IPEG guideline on statistical design and analysis for pharmacodynamic trials. Neuropsychobiology 39: 92-100
17. Grünberger J (1977) Psychodiagnostik des Alkoholkranken. Ein methodischer Beitrag zur Bestimmung der Organizität in der Psychiatrie. Maudrich, Vienna
18. Guilleminault C, Cetel M, Philip P (1993) Dopaminergic treatment of restless legs and rebound phenomenon. Neurology 43 (2): 445
19. Hajak G and SINE (Study of Insomnia in Europe) Study Group (2001) Epidemiology of severe insomnia and its consequences in Germany. Eur Arch Psychiatry Clin Neurosci 251: 49-56
20. Hening W, Allen R, Earley C, Kushida C, Picchietti D, Silber M (1999) The treatment of restless legs syndrome and periodic limb movement disorder. Sleep 22(7): 970-999
21. Johns MW (1991) A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep 14(6): 540-545
22. Kaplan PW, Allen RP, Buchholz DW, Walters JK (1993) A double-blind, placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa/levodopa and proxyphene. Sleep 16: 717-723
23. Lin SC, Kaplan J, Burger CD, Fredrickson PA (1998) Effect of pramipexole in treatment of resistant restless legs syndrome. Mayo Clin Proc 73(6): 497-500
24. Mezzich JE, Ruiperez MA, Perez C, Yoon G, Liu J, Mahmud S (2000) The Spanish version of the quality of life index: presentation and validation. Nerv Ment Dis 188(5): 301-305
25. Monti JM, Hawkins M, Jantos H, D'Angelo L, Fernández I (1988) Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat. Psychopharmacology 9: 395-400
26. Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B (1999) Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology 52: 938-943
27. Montplaisir J, Denesle R, Petit D (2000) Pramipexole in the treatment of restless legs syndrome: a follow-up study. Eur J Neurol 7 (Suppl 1): 27-31
28. Paik IH, Lee C, Choi BM, Chae YL, Kim CE (1989) Mianserin-induced restless legs syndrome. Br J Psychiatry 155: 415-417
29. Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Brain Information Service, Los Angeles
30. Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K (2000) Prevalence and risk factors of RLS in an elderly population: the memo study. Memory and morbidity in Augsburg elderly. Neurology 14(54): 1064-1068
31. Saletu B, Wessely P, Grünberger J, Schultes M (1987) Erste klinische Erfahrungen mit einem neuen schlafanstoßenden Benzodiazepin, Cinolazepam, mittels eines Selbstbeurteilungsbogens für Schlaf- und Aufwachqualität (SSA). Neuropsychiatrie 1: 169-174
32. Saletu B, Anderer P, Frey R, Krupka M, Klösch G (1991) Zur Neurophysiologie des Schlafes. Some remarks about the neurophysiology of sleep. Psychiatria Danubina 3(1-2): 31-58
33. Saletu B, Frey R, Krupka M, Anderer P, Grünberger J, See WR (1991) Sleep laboratory studies on the single-dose effects of serotonin reuptake inhibitors paroxetine and fluoxetine on human sleep and awakening qualities. Sleep 14(5): 439-447
34. Saletu B, Brandstätter N, Metka M, Stamenkovic M, Anderer P, Semlitsch HV, Heytmanek G, Huber J, Grünberger J, Linzmayer L, Kurz Ch, Decker K, Binder G, Knogler W, Koll B (1996) Hormonal, syndromal and EEG mapping studies in menopausal syndrome patients with and without depression as compared with controls. Maturitas 23(1): 91-105
35. Saletu B, Gruber G, Saletu M, Brandstätter N, Hauer C, Prause W, Ritter K, Saletu-Zyhlarz G (2000) Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole: I) Findings on objective and subjective sleep and awakening quality. Neuropsychobiology 41: 181-189
36. Saletu B, Saletu-Zyhlarz GM (2001) Was Sie schon immer über Schlaf wissen wollten. Ueberreuter, Wien
37. Saletu B, Prause W, Löffler H, Anderer P, Brandstätter N, Zoghlami A, Saletu-Zyhlarz, G, Katschnig H (2002) Quality of life in nonorganic and organic sleep disorders: I. Comparison with normative data. Wien Klin Wochenschr (in press)
38. Saletu M, Anderer P, Saletu B, Hauer C, Mandl M, Oberndorfer S, Zoghlami A, Saletu-Zyhlarz G (2000) Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole: II) Findings on periodic leg movements, arousals and respiratory variables. Neuropsychobiology 41:190-199
39. Saletu M, Anderer P, Saletu-Zyhlarz G, Prause W, Semler B, Zoghlami A, Gruber G, Hauer C, Saletu B (2001) Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) - acute placebo-controlled sleep laboratory studies with clonazepam. Eur Neuropsychopharmacol 11(2): 153-161
40. Saletu M, Anderer P, Saletu B, Lindeck-Pozza L, Hauer C, Saletu-Zyhlarz G (2002a) EEG mapping in patients with restless legs syndrome as compared with normal controls. Psychiatry Research - Neuroimaging 115: 49-61
41. Saletu M, Anderer P, Högl B, Saletu-Zyhlarz G, Kunz A, Poewe W, Saletu B. (2002b) Acute double-blind, placebo- controlled sleep laboratory and clinical follow-up studies with a combination treatment of RR-L-dopa and SR-L-dopa in restless legs syndrome. Journal of Sleep Research 11(Suppl 1): 200
42. Saletu-Zyhlarz GM, Hassan Abu-Bakr M, Anderer P, Semler B, Decker K,Parapatics S, Tschida U, Winkler A, Saletu B (2001) Insomnia related to dysthymia: polysomnographic and psychometric comparison with normal controls and acute therapeutic trials with trazodone. Neuropsychobiology 44(3):139-149
43. Saletu-Zyhlarz GM, Hassan Abu-Bakr M, Anderer P, Gruber G, Mandl M, Strobl R, Gollner D, Prause W, Saletu B (2002) Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone. Prog Neuropsychopharmacol Biol Psychiatry 26(2): 249-260
44. Schaefer E, Leimer I, Haeselbarth V, Meier D (1996) Tolerability of pramipexole in patients hospitalized for major depression disorder: an open-label study to assess the maximum tolerated dose of pramipexole with repeated dosing. Clinical Trial Report N. U96-0084
45. Siever LJ, Davis KL (1985) Overview: toward a dysregulation hypothesis of depression. Am J Psychiatry 142(9): 1017-1031
46. Stiasny K, Robbecke J, Schuler P, Oertel WH (2000) Treatment of idiopathic restless legs syndrome (RLS) with the D2-agonist cabergoline - an open clinical trial. Sleep 23(3): 349-354
47. Trenkwalder C, Stiasny K, Pollmächter T, Wetter TC, Schwarz J, Kohnen R, Kazenwadel J, Ramm S, Oertel WH (1995) L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind crossover trial. Sleep 18: 681-688
48. Von Zerssen D, Koeller DM, Rey ER (1970) Die Befindlichkeitsskala (B-S) - Ein einfaches Instrument zur Objektivierung von Befindlichkeitsstörungen, insbesondere im Rahmen von Längsschnittuntersuchungen. Arzneim Forsch Drug Res 20: 915-918
49. Walters AS and The International Restless Legs Syndrome Study Group (1995) Toward a better definition of restless legs syndrome. Mov Disord 10: 634-642
50. Ware JC, Brown FW, Moorad PJ, Pittard JT, Murphy M, Franklin D (1984) Nocturnal myoclonus and tricyclic antidepressants. Sleep Res 13: 72
51. Wetter TC, Stiasny K, Winkelmann J, Buhlinger A, Brandenburg U, Penzel T, Medori R, Rubin M, Oertel WH, Trenkwalder C (1999) A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology 52: 944-950
52. Whittmack T (1861) Pathologie und Therapie der Sensibilitäts-Neurosen. Schäfer, Leipzig
53. Willis T (1685) The London Practice of Physick. Bassett and Crook, London
54. Willner P, Lapas S, Cheeta S, Muscat R (1994) Reversal of stress induced anhedonia by the dopamine agonist, pramipexole. Psychopharmacol 115: 454-462
55. Zung WWK (1965) A self-rating depression scale. Arch Gen Psychiat 12: 63-70
56. Zung WWK (1976) SAS, Self-Rating Anxiety Scale. In: Guy W (ed) ECDEU Assessment Manual for Psychopharmacology, revised ed, Rockville, Maryland, pp 337-340